Redox-dependent regulation of epidermal growth factor receptor signaling

Redox-dependent regulation of epidermal growth factor receptor signaling

Tyrosine phosphorylation-dependent cell signaling represents a unique feature of multicellular organisms, and is important in regulation of cell differentiation and specialized cell functions. Multicellular organisms also contain a diverse family of NADPH oxidases (NOXs) that have been closely linke...

ver descrição completa

Detalhes bibliográficos
Main Authors:	David E. Heppner, Albert van der Vliet
Formato:	Artigo
Idioma:	English
Publicado em:	Elsevier 2016-08-01
Colecção:	Redox Biology
Assuntos:	NADPH oxidase NOX/DUOX EGFR Tyrosine phosphatase Tyrosine kinase Cysteine oxidation
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2213231715300173

Registos relacionados

Identification of DUOX1-dependent redox signaling through protein S-glutathionylation in airway epithelial cells
Por: Milena Hristova, et al.
Publicado em: (2014-01-01)

Redox Dysregulation in Aging and COPD: Role of NOX Enzymes and Implications for Antioxidant Strategies
Por: Caspar Schiffers, et al.
Publicado em: (2021-11-01)

H<sub>2</sub>O<sub>2</sub> Metabolism in Normal Thyroid Cells and in Thyroid Tumorigenesis: Focus on NADPH Oxidases
Por: Ildiko Szanto, et al.
Publicado em: (2019-05-01)

VEO-IBD NOX1 variant highlights a structural region essential for NOX/DUOX catalytic activity
Por: Josie Ward, et al.
Publicado em: (2023-11-01)

NADPH Alters DUOX1 Calcium Responsiveness
Por: Gregory E. Conner
Publicado em: (2024-09-01)

Hydrogen peroxide production by epidermal dual oxidase 1 regulates nociceptive sensory signals
Por: Anna Pató, et al.
Publicado em: (2023-06-01)

Exploring redox vulnerabilities in JAK2V617F-positive cellular models
Por: Keli Lima, et al.
Publicado em: (2021-10-01)

Calcium-Dependent Src Phosphorylation and Reactive Oxygen Species Generation Are Implicated in the Activation of Human Platelet Induced by Thromboxane A2 Analogs
Por: Pietro Minuz, et al.
Publicado em: (2018-09-01)

NADPH Oxidase and Epidermal Growth Factor Receptor Are Promising Targets of Phytochemicals for Ultraviolet-Induced Skin Carcinogenesis
Por: Min Jeong Kim, et al.
Publicado em: (2021-11-01)

Structural insights into redox-active cysteine residues of the Src family kinases
Por: David E. Heppner
Publicado em: (2021-05-01)

Zebrafish Models to Study the Crosstalk between Inflammation and NADPH Oxidase-Derived Oxidative Stress in Melanoma
Por: Irene Pardo-Sánchez, et al.
Publicado em: (2022-06-01)

The experimental study of the pathogenic role of NADPH-oxidase in the thyroid gland tissues
Por: Irina BAGMUT, et al.
Publicado em: (2019-03-01)

Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR)
Por: Nichole E. M. Kaufman, et al.
Publicado em: (2021-02-01)

Use of an Anaerobic Chamber Environment for the Assay of Endogenous Cellular Protein-Tyrosine Phosphatase Activities
Por: Zhu Li, et al.
Publicado em: (2002-01-01)

Regulation of dual oxidase hydrogen peroxide synthesis results in an epithelial respiratory burst
Por: Gregory E. Conner
Publicado em: (2021-05-01)

Implication of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase and Its Inhibitors in Alzheimer’s Disease Murine Models
Por: Leticia Guadalupe Fragoso-Morales, et al.
Publicado em: (2021-02-01)

Restrained glycoprotein VI-induced platelet signaling by tyrosine protein phosphatases independent of phospholipase Cγ2
Por: Jingnan Huang, et al.
Publicado em: (2023-10-01)

Inhibiting NADPH Oxidases to Target Vascular and Other Pathologies: An Update on Recent Experimental and Clinical Studies
Por: Anthony L. Sylvester, et al.
Publicado em: (2022-06-01)

Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic response
Por: Sean P. Korpela, et al.
Publicado em: (2021-01-01)

Merlin deficiency alters the redox management program in breast cancer
Por: Mateus Mota, et al.
Publicado em: (2021-04-01)

The Anti-Fungal Activity of Nitropropenyl Benzodioxole (NPBD), a Redox-Thiol Oxidant and Tyrosine Phosphatase Inhibitor
Por: Gina Nicoletti, et al.
Publicado em: (2022-09-01)

NOX1-dependent redox signaling potentiates colonic stem cell proliferation to adapt to the intestinal microbiota by linking EGFR and TLR activation
Por: Sjoerd van der Post, et al.
Publicado em: (2021-04-01)

Formyl-peptide receptor 2 signalling triggers aerobic metabolism of glucose through Nox2-dependent modulation of pyruvate dehydrogenase activity
Por: Tiziana Pecchillo Cimmino, et al.
Publicado em: (2023-10-01)

NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses
Por: Fan Jiang, et al.
Publicado em: (2014-01-01)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
Por: Xu H, et al.
Publicado em: (2019-07-01)

Tyrosine Kinases and Phosphatases: Enablers of the Porphyromonas gingivalis Lifestyle
Por: Richard J. Lamont, et al.
Publicado em: (2022-02-01)

Editorial: Tyrosine kinases and phosphatases in T- cell malignancies
Por: Melania Tesio
Publicado em: (2024-02-01)

Di-Tyrosine Crosslinking and <i>NOX4</i> Expression as Oxidative Pathological Markers in the Lungs of Patients with Idiopathic Pulmonary Fibrosis
Por: Sanja Blaskovic, et al.
Publicado em: (2021-11-01)

In silico and in vitro evaluation of novel carbothioamide-based and heterocyclic derivatives of 4-(tert-butyl)-3-methoxybenzoic acid as EGFR tyrosine kinase allosteric site inhibitors
Por: Imad M. Al-Rubaye, et al.
Publicado em: (2024-01-01)

Concomitant Pulmonary Tuberculosis Impair Survival in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Lung Adenocarcinoma Patients Receiving EGFR-Tyrosine Kinase Inhibitor
Por: Xie Y, et al.
Publicado em: (2021-10-01)

Protein redox chemistry: post-translational cysteine modifications that regulate signal transduction and drug pharmacology
Por: Revati eWani, et al.
Publicado em: (2014-10-01)

A preliminary results of integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small-cell-lung cancer harboring EGFR mutation
Por: K. K. Laktionov, et al.
Publicado em: (2019-06-01)

A rotamer relay information system in the epidermal growth factor receptor–drug complexes reveals clues to new paradigm in protein conformational change
Por: Tareq Hameduh, et al.
Publicado em: (2021-01-01)

Case report: Neonatal-onset inflammatory bowel disease due to novel compound heterozygous mutations in DUOX2
Por: Andrea Finocchi, et al.
Publicado em: (2023-11-01)

Epidermal Growth Factor Receptor Family and its Role in Gastric Cancer
Por: Chiara Arienti, et al.
Publicado em: (2019-11-01)

Clinicopathological Characteristics and Real-life Data of Patients Receiving Tyrosine Kinase Inhibitor in Metastatic EGFR Mutant Non-small Cell Lung Carcinoma
Por: Barış EKİNCİ, et al.
Publicado em: (2023-12-01)

Virtual screening of Osimertinib and Dacomitinib Analogues with potential activity on EGFR (T790M and l858R Mutations) for non-small cell lung cancer treatment
Por: Leydis Luna Torres, et al.
Publicado em: (2021-10-01)

Vascular NADPH Oxidases and Atherothrombotic Stroke
Por: Javier Marqués, et al.
Publicado em: (2024-09-01)

The Effects of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase and Erythropoietin, and Their Interactions in Angiogenesis: Implications in Retinopathy of Prematurity
Por: Thaonhi Cung, et al.
Publicado em: (2022-06-01)

NOX2 and NOX4 expression in monocytes and macrophages-extracellular vesicles in signalling and therapeutics
Por: Deepak Rathi, et al.
Publicado em: (2024-04-01)